{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:08:29Z","timestamp":1792058909935,"version":"4.4.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Learning Objectives<\/jats:title>\n                  <jats:p>After completing this course, the reader will be able to: Describe the origin and clinical burden of HNSCC.Explain the concept of field malignancy.Discuss the potential of prevention research in HNSCC.<\/jats:p>\n                  <jats:p>Access and take the CME test online and receive 1 hour of AMA PRA category 1 credit at CME.TheOncologist.com<\/jats:p>\n                  <jats:p>Recent molecular genetic studies provide evidence that the majority of, if not all, head and neck squamous cell carcinomas (HNSCCs) develop within a contiguous field of preneoplastic cells. Cells of a field show genetic alterations associated with the process of carcinogenesis. A subclone in a field gives rise to an invasive carcinoma. An important implication of this knowledge is that, after surgery of the initial carcinoma, part of the field may remain in the patient. A field with preneoplastic cells that share genetic alterations with cells of the excised tumor has been detected in the resection margins of at least 25% of patients, indicating that this frequently occurs. Fields can be much larger than the actual carcinoma, sometimes having a diameter &amp;gt;7 cm. When a field remains after resection of the tumor, the risk for another carcinoma, designated as a second field tumor (SFT), is considerably greater. It is important to realize that an SFT develops from preneoplastic cells clonally related to the initial tumor. In this respect, it should be discriminated from a recurrent carcinoma that has developed from minimal residual cancer that was left behind and from a second primary tumor that independently develops from the initial carcinoma. Patients at risk for SFTs belong to a unique patient group for whom intense surveillance is indicated and chemoprevention is an attractive option. The priorities are to identify the patients in whom a remaining field will progress to cancer and to find the genes involved. With this knowledge, highly efficient clinical prevention trials, including those using the local application of therapeutic agents, can be designed. It is important to note that SFTs also may occur after treatment of various other cancers, including those of the bladder, skin, esophagus, lung, cervix, breast, and colon.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.10-7-493","type":"journal-article","created":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T20:07:43Z","timestamp":1123099663000},"page":"493-500","source":"Crossref","is-referenced-by-count":70,"title":["Second Field Tumors: A New Opportunity for Cancer Prevention?"],"prefix":"10.1093","volume":"10","author":[{"given":"Boudewijn J.M.","family":"Braakhuis","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\/Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud H.","family":"Brakenhoff","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\/Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ren\u00e9","family":"Leemans","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\/Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,8,1]]},"reference":[{"key":"2021122209513135100_R1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0959-8049(01)00350-1","article-title":"Estimates of cancer incidence and mortality in Europe in 1995","volume":"38","author":"Bray","year":"2002","journal-title":"Eur J Cancer"},{"key":"2021122209513135100_R2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.1571","article-title":"Estimates of the world-wide prevalence of cancer for 25 sites in the adult population","volume":"97","author":"Pisani","year":"2002","journal-title":"Int J Cancer"},{"key":"2021122209513135100_R3","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMra001375","article-title":"Head and neck cancer","volume":"345","author":"Forastiere","year":"2001","journal-title":"N Engl J Med"},{"key":"2021122209513135100_R4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/1097-0142(19940101)73:1<187::AID-CNCR2820730132>3.0.CO;2-J","article-title":"Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor","volume":"73","author":"Leemans","year":"1994","journal-title":"Cancer"},{"key":"2021122209513135100_R5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/1097-0142(19930115)71:2<452::AID-CNCR2820710228>3.0.CO;2-B","article-title":"Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma","volume":"71","author":"Leemans","year":"1993","journal-title":"Cancer"},{"key":"2021122209513135100_R6","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/000348949510401206","article-title":"Second primary malignancies in the head and neck cancer patient","volume":"104","author":"Sturgis","year":"1995","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2021122209513135100_R7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0277-5379(87)90297-5","article-title":"Second primary cancers in the lung in head and neck cancer patients: a challenge","volume":"23","author":"Snow","year":"1987","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2021122209513135100_R8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hed.10042","article-title":"Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions","volume":"24","author":"Braakhuis","year":"2002","journal-title":"Head Neck"},{"key":"2021122209513135100_R9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hed.2890010203","article-title":"The significance of \u201cpositive\u201d margins in surgically resected epidermoid carcinomas","volume":"1","author":"Looser","year":"1978","journal-title":"Head Neck Surg"},{"key":"2021122209513135100_R10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/jnci\/91.13.1113","article-title":"Detection and clinical importance of micro-metastatic disease","volume":"91","author":"Pantel","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2021122209513135100_R11","first-page":"21","volume-title":"World Health Organization","author":"Pindborg","year":"1997"},{"key":"2021122209513135100_R12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1368-8375(98)80007-9","article-title":"Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands","volume":"34","author":"Schepman","year":"1998","journal-title":"Oral Oncol"},{"key":"2021122209513135100_R13","first-page":"357","article-title":"Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia","volume":"6","author":"Rosin","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2021122209513135100_R14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM200104263441702","article-title":"DNA content as a prognostic marker in patients with oral leukoplakia","volume":"344","author":"Sudbo","year":"2001","journal-title":"N Engl J Med"},{"key":"2021122209513135100_R15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S1079-2104(05)80201-X","article-title":"Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia","volume":"80","author":"Abbey","year":"1995","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2021122209513135100_R16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0714.1995.tb01166.x","article-title":"Observer variability in the histologic assessment of oral premalignant lesions","volume":"24","author":"Karabulut","year":"1995","journal-title":"J Oral Pathol Med"},{"key":"2021122209513135100_R17","first-page":"1358","article-title":"Multiple primary malignant tumors. A survey of the literature and a statistical study","volume":"16","author":"Warren","year":"1932","journal-title":"Am J Cancer"},{"key":"2021122209513135100_R18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM199009203231205","article-title":"Prevention of second primary tumors with isotretinoin in squamouscell carcinoma of the head and neck","volume":"323","author":"Hong","year":"1990","journal-title":"N Engl J Med"},{"key":"2021122209513135100_R19","first-page":"2484","article-title":"Multiple head and neck tumors: evidence for a common clonal origin","volume":"56","author":"Bedi","year":"1996","journal-title":"Cancer Res"},{"key":"2021122209513135100_R20","first-page":"2003","article-title":"Synchronous oral carcinomas: independent or common clonal origin?","volume":"58","author":"Scholes","year":"1998","journal-title":"Cancer Res"},{"key":"2021122209513135100_R21","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0002-9440(10)64266-6","article-title":"Multiple head and neck tumors frequently originate from a single preneoplastic lesion","volume":"161","author":"Tabor","year":"2002","journal-title":"Am J Pathol"},{"key":"2021122209513135100_R22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ijc.20379","article-title":"Molecular pathology of head-and-neck cancer","volume":"112","author":"Kim","year":"2004","journal-title":"Int J Cancer"},{"key":"2021122209513135100_R23","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1200\/JCO.2004.01.094","article-title":"Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck","volume":"22","author":"Wreesmann","year":"2004","journal-title":"J Clin Oncol"},{"key":"2021122209513135100_R24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.LAB.0000047489.26246.E1","article-title":"Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas","volume":"83","author":"Beder","year":"2003","journal-title":"Lab Invest"},{"key":"2021122209513135100_R25","first-page":"1727","article-title":"A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications","volume":"63","author":"Braakhuis","year":"2003","journal-title":"Cancer Res"},{"key":"2021122209513135100_R26","first-page":"1702","article-title":"Predicting cancer development in oral leukoplakia: ten years of translational research","volume":"6","author":"Lee","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2021122209513135100_R27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","article-title":"Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin","volume":"6","author":"Slaughter","year":"1953","journal-title":"Cancer"},{"key":"2021122209513135100_R28","first-page":"1523","article-title":"Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications","volume":"7","author":"Tabor","year":"2001","journal-title":"Clin Cancer Res"},{"key":"2021122209513135100_R29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/path.1285","article-title":"Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx","volume":"199","author":"Tabor","year":"2003","journal-title":"J Pathol"},{"key":"2021122209513135100_R30","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1158\/1078-0432.CCR-03-0632","article-title":"Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study","volume":"10","author":"Tabor","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2021122209513135100_R31","first-page":"2718","article-title":"Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment","volume":"6","author":"Partridge","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2021122209513135100_R32","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1158\/1078-0432.CCR-03-0631","article-title":"Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study","volume":"10","author":"van Houten","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2021122209513135100_R33","first-page":"1862","article-title":"Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships","volume":"5","author":"Califano","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2021122209513135100_R34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0046-8177(95)90054-3","article-title":"Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization","volume":"26","author":"Worsham","year":"1995","journal-title":"Hum Pathol"},{"key":"2021122209513135100_R35","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/sj.onc.1204311","article-title":"Multiple oral squamous epithelial lesions: are they genetically related?","volume":"20","author":"Jang","year":"2001","journal-title":"Oncogene"},{"key":"2021122209513135100_R36","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJMoa033374","article-title":"The influence of resection and aneuploidy on mortality in oral leukoplakia","volume":"350","author":"Sudbo","year":"2004","journal-title":"N Engl J Med"},{"key":"2021122209513135100_R37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.canlet.2004.10.023","article-title":"Radiotherapy for oral cancer as a risk factor for second primary cancers","volume":"220","author":"Hashibe","year":"2005","journal-title":"Cancer Lett"},{"key":"2021122209513135100_R38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-9896(199603)178:3<284::AID-PATH470>3.0.CO;2-9","article-title":"Potential early markers of carcinogenesis in the mucosa of the head and neck using exfoliative cytology","volume":"178","author":"Bongers","year":"1996","journal-title":"J Pathol"},{"key":"2021122209513135100_R39","first-page":"3803","article-title":"Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions","volume":"6","author":"van Houten","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2021122209513135100_R40","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1200\/JCO.2003.03.544","article-title":"An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia","volume":"21","author":"Rudin","year":"2003","journal-title":"J Clin Oncol"},{"key":"2021122209513135100_R41","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1172\/JCI119748","article-title":"Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis","volume":"100","author":"Franklin","year":"1997","journal-title":"J Clin Invest"},{"key":"2021122209513135100_R42","first-page":"4784","article-title":"p53-mutant clones and field effects in Barrett's esophagus","volume":"59","author":"Prevo","year":"1999","journal-title":"Cancer Res"},{"key":"2021122209513135100_R43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ijc.10362","article-title":"Molecular evidence of a common clonal origin and subsequent divergent clonal evolution in vulval intraepithelial neoplasia, vulval squamous cell carcinoma and lymph node metastases","volume":"99","author":"Rosenthal","year":"2002","journal-title":"Int J Cancer"},{"key":"2021122209513135100_R44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1098-2264(199902)24:2<127::AID-GCC5>3.0.CO;2-8","article-title":"Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution","volume":"24","author":"Chu","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"2021122209513135100_R45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000217967","article-title":"Field effect of human colon carcinoma on normal mucosa: relevance of carcinoembryonic antigen expression","volume":"17","author":"Jothy","year":"1996","journal-title":"Tumour Biol"},{"key":"2021122209513135100_R46","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0959-8049(01)00118-6","article-title":"Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer","volume":"37","author":"Forsti","year":"2001","journal-title":"Eur J Cancer"},{"key":"2021122209513135100_R47","first-page":"5835","article-title":"Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract","volume":"58","author":"Takahashi","year":"1998","journal-title":"Cancer Res"},{"key":"2021122209513135100_R48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1523-1747.2002.01814.x","article-title":"p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization","volume":"119","author":"Stern","year":"2002","journal-title":"J Invest Dermatol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.10-7-493","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.10-7-493","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/10\/7\/493\/41852590\/oncolo_10_7_493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/10\/7\/493\/41852590\/oncolo_10_7_493.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T17:39:58Z","timestamp":1640194798000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/10\/7\/493\/6387468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,1]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2005,8,1]]},"published-print":{"date-parts":[[2005,8,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.10-7-493","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,8,1]]},"published":{"date-parts":[[2005,8,1]]}}}